TORONTO (PRWEB)
September 20, 2022

The last two decades have led to increased use of technological solutions in clinical trials and a broader acceptance of such approaches in the industry and by governmental agencies and ethics committees. This evolution has changed how we conduct trials, how CROs bid, and how sponsors improve trial oversight by accessing trial data in real-time.

However, how do you know which is the right solution for your planned trial, what to look for when purchasing such solutions and services, and what are the benefits and how do they translate to the sponsors?

This webinar will highlight how a fully unified digital ecosystem is impacting study management and how these new approaches are impacting study budgeting through an interactive discussion from multiple perspectives (Biotech, CRO and procurement specialist). In this panel, we will share with you different case studies and success measures to get your studies running in an efficient, cost-effective manner. Thanks to the technology used, sponsors receive a more transparent overview of their studies and fewer change orders are required.

During our online discussion, the featured speakers will focus on:

• The current state of trial technology;
• How important is the interconnection of systems?
• How are CROs budgeting for their solutions?
• How do efficiencies translate to the sponsors?
• How can sponsors get a feel for CRO solutions?
• And how does the future look like?

Join this webinar to learn how a fully unified digital ecosystem impacts study stakeholders in their trial management approach and how these novel approaches influence the budgeting of studies. The webinar will be followed by a Q&A session to answer all your questions.

Join Patrick McManus, Chief Development Officer, Clinscience; Leif Kuse, CEO and Founder, Pharall; and Robert Dobosz, Director of Clinical Operations, Ryvu Therapeutics, for the live webinar on Thursday, October 6, 2022, at 10am EDT (3pm BST/UK).

For more information, or to register for this event, visit Clinical Trial Budgeting and Execution: The Impact of a Unified, Digital Ecosystem and Real-time Data Analytics.

ABOUT CLINSCIENCE

Clinscience is a global SMART CRO with hubs across five countries in Europe and the United States; as well as offers a satellite presence in five European countries. Since 2020, Clinscience offers full (end-to-end) CRO services from Protocol Development to Final Study Report. Over 150 Biotech Clients trust Our Brand and we expect many more in the near future. Clinscience specializes in Oncology, Hemato-Oncology, Cardiovascular Diseases, and Neurology. It has managed more than 500 studies and recruited over 157,352 patients across 3,974 sites globally. The Company’s procedures and Data-driven approach, harnessed with the Genius Suite™ technology, work together to give the Clients power and flexibility to address even the most unique needs. Clinscience is part of a publicly-traded parent company, Neuca Plc, an organization in the pharmaceutical wholesaling and healthcare industry that provides the structure to meet the needs of commercial and non-commercial studies. Visit http://www.clinscience.com for more information.

Clinscience Press Contact:

Agnieszka Piotrowska

Email: a.piotrowska@lensomai.com

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email: